Purchase Order 75P00226P00004
- Not listed
- This federal contract award, valued at $10,638,400.00, was issued by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc. (doing business as Intercell USA Inc.), a specialty vaccine company, for the supply of the Japanese encephalitis vaccine IXIARO. The contract is a firm fixed price delivery order with a period of performance through September 30, 2024. Valneva USA, a subsidiary of the France-based Valneva SE, is the prime contractor and holds several other significant...
- This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Valneva USA, Inc. - doing business as Intercell USA Inc. - to provide Japanese encephalitis vaccine. The contract has a potential value of $190,690.00 and a completion date of February 14, 2022. Valneva USA, a subsidiary of the specialty vaccine company Valneva SE, holds multiple indefinite-delivery/indefinite-quantity contracts with the Defense Logistics Agency...
- This is a federal contract award to Valneva USA, Inc., doing business as Intercell USA Inc., for the supply of the IXIARO Japanese encephalitis vaccine. The $86,608.50 fixed-price purchase order was awarded on February 25, 2016 by the Office of the Assistant Secretary for Administration, a civilian federal agency. The contract has a completion date of March 11, 2016 and was not set aside for any specific business type. Valneva USA is a foreign-owned, for-profit organization that specializes in...
- The Department of Veterans Affairs Veterans Health Administration has awarded a firm fixed-price delivery order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.) for the Japanese Encephalitis Vaccine (IXIARO). The $237,264.00 contract, which has no set-aside designation, will be performed in Bethesda, Maryland and runs through April 19, 2024. Valneva USA, Inc. is a subsidiary of the specialty vaccine company Valneva SE, which develops and manufactures vaccines to address...
- This is a delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Administration to Valneva USA, Inc., which does business as Intercell USA Inc. The contract is for the supply of the IXIARO vaccine, a Japanese encephalitis vaccine, with a firm fixed price of $130,235.00 and a completion date of June 15, 2019. The contract is not set aside and is issued under Valneva USA's General Services Administration Schedule 61-IB contract for...
- This is a firm fixed-price delivery order awarded by the Office of the Assistant Secretary for Administration, a civilian federal agency, to Valneva USA, Inc. (dba Intercell USA Inc.), a foreign-owned for-profit organization. The $18,760.75 order is for the supply of the Japanese encephalitis vaccine IXIARO, which is being delivered against Valneva USA's General Services Administration (GSA) Schedule 61-IB contract for Pharmaceuticals and Drugs. This order has an ultimate completion date of...
- The Department of Veterans Affairs Veterans Health Administration awarded a delivery order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.), a subsidiary of Valneva SE, for the provision of the Japanese Encephalitis Virus Vaccine (IXIARO). This $249,648.00 firm fixed price contract has a completion date of March 25, 2025 and was awarded on March 26, 2024. The contract is under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not have a set-aside...
- Valneva USA, Inc. (doing business as Intercell USA Inc.) was awarded a $710,457 firm fixed-price delivery order by the Department of Veterans Affairs, Veterans Integrated Service Network 12, on November 1, 2025, for the supply of Japanese Encephalitis Virus Vaccine IXIARO. The contract is scheduled for completion by September 30, 2026, with performance taking place in Bethesda, Maryland. This delivery order was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and...
- This is a firm fixed-price delivery order awarded by the Bureau of Medical Services, a civilian agency, to Valneva USA, Inc. (doing business as Intercell USA Inc.), a foreign-owned for-profit organization. The order is for the supply of the IXIARO Japanese encephalitis vaccine, with an ultimate completion date of September 30, 2024 and a ceiling value of $56,646.00. The contract was issued under the General Services Administration (GSA) Pharmaceutical and Drugs Federal Supply Schedule...
- This is a $16,016,000.00 firm fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc. (doing business as Intercell USA Inc.), a subsidiary of the French specialty vaccine company Valneva SE. The contract is for the supply of the Japanese encephalitis vaccine IXIARO. This delivery order is part of a larger $48,025,600 indefinite delivery contract awarded to Valneva USA in September 2023, which supports the Department of Defense's medical...
The U.S. Department of State's Office of the Assistant Secretary for Administration awarded a $172,232 firm fixed-price purchase order to Valneva USA, Inc. (doing business as Intercell USA Inc.) on January 6, 2026, for Japanese encephalitis vaccine to protect State Department personnel and their families. The contract carries a total small business set-aside designation and is scheduled for completion by January 6, 2026, with performance taking place in Bethesda, Maryland. Valneva USA is a subsidiary of French vaccine manufacturer Valneva SE and specializes in developing and delivering vaccines for infectious diseases, with particular expertise in the IXIARO Japanese encephalitis vaccine. This award reflects the company's established role as a critical supplier of vaccines to federal agencies. Valneva USA maintains substantial indefinite delivery contracts with the Defense Logistics Agency Troop Support Medical valued at approximately $49 million and $48 million respectively, as well as a Federal Supply Schedule contract with the Department of Veterans Affairs worth over $4 million through September 2030. The company has consistently provided vaccines across multiple federal entities including the Department of Defense, Department of Health and Human Services, and the Federal Bureau of Investigation, positioning it as a key strategic partner for government medical countermeasures and personnel health protection programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $172.2k | 1/6/26 |